stockrowEnovis Corporation (ENOV) vs TransMedics Group, Inc. (TMDX)
- Enovis Corporation ENOV 27.07 −5.42%
- TransMedics Group, Inc. TMDX 88.15 +27.79%
Enovis Corporation and TransMedics Group, Inc. are both Medical Devices companies. TransMedics Group, Inc. is the larger, with a market value of $2.4B against $1.7B — 1.4× the size. Enovis Corporation has negative trailing earnings, so its P/E is not meaningful; TransMedics Group, Inc. trades at 21.0×. TransMedics Group, Inc. grew revenue faster over the last twelve months: 28.5% against 3.28%. TransMedics Group, Inc. has the higher net margin (19.9% vs −22.9%) and the higher return on invested capital (48.0% vs −10.8%). Across the 20 metrics below, TransMedics Group, Inc. leads on 13 and Enovis Corporation on 7.
Valuation
Profitability
| Metric | ENOV | TMDX | Medical Devices median |
|---|---|---|---|
| Gross margin | 61.31% | 58.60% | 57.76% |
| Operating margin | (20.59%) | 11.88% | (14.84%) |
| Net margin | (22.87%) | 19.85% | (14.45%) |
| Free cash flow margin | 3.02% | 6.14% | (5.70%) |
| Return on equity | (29.97%) | 31.89% | (10.56%) |
| Return on assets | (12.91%) | 11.73% | (17.26%) |
| Return on invested capital | (10.83%) | 48.00% | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack